Connect your AI

Zimmer Biomet Holdings ZBH Total Equity

Total Equity at other companies

Johnson & JohnsonJNJ

$81.19B+3.9%

PDE

Pro-Dex, Inc.PDEX

$45.2M+28.1%

CONMEDCNMD

$1.02B+4.1%

VericelVCEL

$356.23M+20.6%

Anika TherapeuticsANIK

$133.9M-9.8%

Globus MedicalGMED

$4.73B+15.8%

Other financials

Income statement

Revenue$2.1B+9.3%

Gross profit$1.5B+11.1%

Operating income$373.2M+27.7%

Net income$238.1M+30.8%

EPS (diluted)$1.22+34.1%

Balance sheet

Cash & equivalents$424.2M-69.4%

Total debt$7.5B+4.1%

Total assets$22.7B+2.4%

Cash flow

Operating cash flow$359.4M-6.1%

CapEx$36.3M-18.6%

Free cash flow$323.1M-4.5%

Valuation

Market cap$17.61B-6.5%

Enterprise value$24.66B-4.6%

P/E23.1×+0.3×

P/S2.1×-0.3×

Profitability

Gross margin70%-1.0pp

Operating margin14%-3.0pp

Net margin9.1%-2.8pp

FCF margin17.3%-1.6pp

Returns & leverage

Return on equity6.1%-1.2pp

Debt / equity0.6×0.0×

Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Zimmer Biomet Holdings's total equity?: Zimmer Biomet Holdings (ZBH) reported total equity of $12.67B in Q1 2026.
How has Zimmer Biomet Holdings's total equity changed year-over-year?: Zimmer Biomet Holdings's total equity increased by 2.2% year-over-year, from $12.4B to $12.67B.
What is the long-term trend for Zimmer Biomet Holdings's total equity?: Over 5 years (2020 to 2025), Zimmer Biomet Holdings's total equity has grown at a 0.8% compound annual growth rate (CAGR), from $12.19B to $12.7B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.